SyntekaBio,Inc. Charter change and inside director approved; independent director item withdrawn
SAI summary · Not investment advice
SyntekaBio,Inc. shareholders approved a charter change, an inside director and other items at an extraordinary meeting. The independent director item was withdrawn after the nominee stepped down.
Key facts
- Meeting date
- Oct 16, 2026
- Agenda item 1
- Partial amendment of the articles of incorporation — approvedSpecial resolution · 99.9% of votes cast in favor · reflects Commercial Act changes and adds business purposes
- Voting record date
- Aug 14, 2026
Commentary
AI commentary · Not investment advice
What happened
SyntekaBio held an extraordinary shareholders' meeting and passed most items. It amended its articles of incorporation to add business purposes such as bio screening, medicines, data centers and AI. Shareholders elected the inside director nominee and the non-standing auditor nominee. They also approved new executive pay rules and grants of stock options (rights to acquire company shares at a set price).
In the company's terms
The item to elect the independent director nominee was withdrawn because the nominee stepped down before the meeting. Approved items won 99.8% to 99.9% of votes cast. After the meeting the board has 3 directors (2 inside, 1 outside) and 1 auditor.
Earlier Shareholders' Meeting filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.10.142026.10.14 | [Amended] Shareholders' Meeting | — |
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist